An interventional study of Prevena Incision Management System and Standard of Care for Surgical Incisions in Surgical Site Reaction, sponsored by KCI USA, Inc. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-16.
Sponsored by KCI USA, Inc · Not applicable, Interventional, and Treatment
This study is being conducted to see how safe and effective the Prevena Incision Management System "Prevena" is when placed over a renal transplantation incision. Prevena provides negative pressure (suction) wound therapy. Prevena will be tested while applied during the time each subject is hospitalized and up to 5 days after the surgery. Prevena is a small portable negative pressure device which consists of a therapy unit that delivers negative pressure. It also includes a dressing system that is intended for use over closed incisions after surgery.
The intent of this study is to evaluate Prevena versus the standard care that a doctor would use normally after a kidney transplant.
This is a randomized, single-center, comparative interventional study looking at the effect of Prevena™ on renal transplant surgical Subjects compared to a control arm treated with the standard-of-care wound dressing. The prospective, post-marketing clinical study described in this protocol will assess the effectiveness and functional performance of PrevenaTM in this clinical indication.
519 studies on the registry are indexed under Surgical Wound; 71 are open to participants now.
This study's enrollment of 63 is below the median of 80 across 412 interventional studies indexed under Surgical Wound.
Browse Surgical Wound studies →KCI USA, Inc is the lead sponsor of 17 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pre-operative Inclusion Criteria
The Subject:
is pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered
Intra-operative Inclusion Criteria Subjects must meet the following intra-operative inclusion criteria to be eligible for randomization.
The Subject:
Pre-operative Exclusion Criteria
The Subject:
is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
Intra-Operative Exclusion Criteria Subjects who meet any of the following intra-operative exclusion criteria are considered screen failures and are not eligible for randomization.
The Subject:
is determined to have a CDC Wound Classification of:
Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
Negative Pressure Therapy Device
Device: Prevena Incision Management System
Sterile gauze and a non-penetrable barrier
Other: Standard of Care for Surgical Incisions
It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT).
Sterile 4X4 Non-Penetrable barrier
Number of Participants With Surgical Site Complications (SSCs)
The primary objective to compare short-term surgical incision-related clinical outcomes in Subjects undergoing open renal transplant surgery when treated with Prevena vs. the standard-of-care wound dressing. Clinical outcomes of interest are defined as Surgical Site Complications (SSCs) that include incisional fluid accumulation (i.e. seroma, hematoma, abscess), dehiscence, surgical site infection (SSI). These outcomes will be compared to a control group consisting of subjects screened for the same inclusion/exclusion criteria but treated with standard-of-care incision dressing.
Time frame: 62 Days
| Milestone | Prevena Incision Management System | Standard of Care for Surgical Incisions |
|---|---|---|
| Started | 31 | 32 |
| Completed | 26 | 29 |
| Not completed | 5 | 3 |
The primary objective to compare short-term surgical incision-related clinical outcomes in Subjects undergoing open renal transplant surgery when treated with Prevena vs. the standard-of-care wound dressing. Clinical outcomes of interest are defined as Surgical Site Complications (SSCs) that include incisional fluid accumulation (i.e. seroma, hematoma, abscess), dehiscence, surgical site infection (SSI). These outcomes will be compared to a control group consisting of subjects screened for the same inclusion/exclusion criteria but treated with standard-of-care incision dressing.
| Participants | Prevena Incision Management System | Standard of Care for Surgical Incisions |
|---|---|---|
| Number of Participants With Surgical Site Complications (SSCs) | 6 | 8 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Prevena Incision Management System | — | 11/31 (35.5%) | 0/31 (0%) |
| Standard of Care for Surgical Incisions | — | 13/32 (40.6%) | 0/32 (0%) |
| Event | Prevena Incision Management System | Standard of Care for Surgical Incisions |
|---|---|---|
| HypercreatininaemiaMetabolism and nutrition disorders | 1/31 | 3/32 |
| Kidney Transplant RejectionImmune system disorders | 2/31 | 0/32 |
| HaematomaVascular disorders | 2/31 | 1/32 |
| Wound DehiscenceInjury, poisoning and procedural complications | 0/31 | 2/32 |
| Myocardial InfarctionCardiac disorders | 1/31 | 0/32 |
| Ankle FractureInjury, poisoning and procedural complications | 1/31 | 0/32 |
| Complications of Transplanted KidneyInjury, poisoning and procedural complications | 1/31 | 0/32 |
| Post Procedural HaemorrhageInjury, poisoning and procedural complications | 1/31 | 1/32 |
| Blood Creatine IncreasedInvestigations | 1/31 | 1/32 |
| Urine Output DecreasedInvestigations | 1/31 | 0/32 |
| Age, Continuous(years) | Prevena Incision Management System | Standard of Care for Surgical Incisions | Total |
|---|---|---|---|
| Mean | 48.71 ± 11.29 | 51.75 ± 12.19 | 50.25 ± 11.76 |
| Sex: Female, Male(Participants) | Prevena Incision Management System | Standard of Care for Surgical Incisions | Total |
|---|---|---|---|
| Female | 9 | 13 | 22 |
| Male | 22 | 19 | 41 |
| Ethnicity (NIH/OMB)(Participants) | Prevena Incision Management System | Standard of Care for Surgical Incisions | Total |
|---|---|---|---|
| Hispanic or Latino | 1 | 5 | 6 |
| Not Hispanic or Latino | 30 | 27 | 57 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Prevena Incision Management System | Standard of Care for Surgical Incisions | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 1 | 1 |
| Asian | 1 | 2 | 3 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 18 | 14 | 32 |
| White | 12 | 15 | 27 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
This study is terminated, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
KCI USA, Inc